Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy, Safety and Tolerability Study of TV-1106 in Growth Hormone-Deficient Adults Who Are Not Current Users of rhGH Treatment

Next Previous
Trial Profile

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy, Safety and Tolerability Study of TV-1106 in Growth Hormone-Deficient Adults Who Are Not Current Users of rhGH Treatment

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Albusomatropin (Primary)
  • Indications Somatotropin deficiency
  • Focus Registrational; Therapeutic Use
  • Sponsors Teva Pharmaceutical Industries

Most Recent Events

  • 03 Apr 2022 This trial has been completed in Italy (End Date: 18 Dec 2015), according to European Clinical Trials Database record.
  • 26 Apr 2016 Status changed from active, no longer recruiting to discontinued as per the Business decision.
  • 02 Mar 2016 Planned End Date changed from 1 Feb 2018 to 1 Apr 2016 ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top